Back to Results
First PageMeta Content
Viruses / Polymerase chain reaction / Virology / HIV/AIDS / Medical tests / Viral load / Hepatitis B / Human cytomegalovirus / Cobas / Biology / Chemistry / Microbiology


Microsoft Word - 150302_HBV_en
Add to Reading List

Document Date: 2015-03-02 00:59:00


Open Document

File Size: 112,48 KB

Share Result on Facebook

City

Basel / /

Company

Roche Group / Roche Diagnostics / Chugai Pharmaceutical / Group M / Genentech / F. Hoffmann-La Roche Ltd / /

Country

Switzerland / Japan / United States / /

Currency

CHF / /

/

/

IndustryTerm

pharmaceuticals / diabetes management / research-focused healthcare / automated solutions / /

MedicalCondition

tissue-based cancer / abdominal pain / HIV / HBV / hepatitis E / transfusion-transmitted infectious diseases / nausea / diabetes / hepatitis C / hepatitis B / HCV / vomiting / fatigue / HBV infections / infectious diseases / infections / /

MedicalTreatment

antibiotics / chemotherapy / antiviral therapy / /

Organization

World Health Organization / /

Person

Nina Schwab-Hautzinger / Claudia Schmitt / Roland Diggelmann / Nicolas Dunant / Ulrike Engels-Lange / Nicole Rüppel / /

/

Position

leader / majority shareholder / Major / COO / Head / /

Region

West Nile / /

Technology

neuroscience / Nobel-prize winning PCR technology / chemotherapy / in vitro diagnostics / /

URL

www.cobas68008800.com / www.roche.com / /

SocialTag